The University of Iowa
The Lentz Laboratory

Lentz Lab Home

Research Projects

Selected Publications

Recent Presentations

Information for Patients

Lab Members

Useful Links

Lab Meeting Schedules

Lab Photos

Lab News

The University of Iowa Health Care

Webmaster:
Katina Wilson

Recent Presentations by Dr. Lentz

2007

Visiting Professor, Iowa State University, Ames, IA. “Vascular Pathophysiology of Hyperhomocysteinemia in Murine Models”

Visiting Professor, Boston University, Boston, MA. “The Homocysteine Paradox”

Visiting Professor, Temple University, Philadelphia, PA. “The Homocysteine Paradox”

Invited Lecture, Hemophilia and Thrombosis Research Society, Chicago, IL. “Risk Factors for Arterial Thrombosis and the Homocysteine Paradox”

Invited Lecture, International Congress on Hyperhomocysteinemia, Sarbrücken, Germany. “Hyperhomocysteinemia Induces Cerebral and Vascular Dysfunction”

Visiting Professor, Almazov Heart, Blood and Endocrinology Institute, St. Petersburg, Russia. “The Role of Homocysteine and ADMA in the Pathogenesis of Vascular Diseases”

Michigan State University, Scott Swisher Grand Rounds. "The Homocysteine Paradox: From Bench to Beside and Back"

Retinal Vascular Diseases Symposium, Vienna, Austria. "Mechanism of Homocysteine-induced Atherothrombosis"

2006

Visiting Professor, University of North Carolina, Chapel Hill, NC. “The Homocysteine Paradox”

Invited Lecture, 4th International Vulnerable Plaque Meeting, Capri, Italy. “The Role of Oxidative Stress in Vascular Anticoagulant Mechanisms”

Invited Lecture, 32nd Penner Blood Coagulation Conference, Kuwait City, Kuwait. “Atherothrombotic Effects of Elevated Homocysteine”

Invited Lecture, 32nd Penner Blood Coagulation Conference, Kuwait City, Kuwait. “Thrombophilia, Estrogens, and Pregnancy”

Visiting Professor, Morehouse School of Medicine, Atlanta, GA. “Vascular Phenotype of Hyperhomocysteinemic Mice”

2005

Meet The Expert Session, American Society of Hematology, Atlanta, GA. “Homocysteine: Physiology and Clinical Relevance”

State of the Art Lecture, XX Congress of the International Society on Thrombosis & Haemostasis, Sydney, Australia. “Mechanisms of Homocysteine-induced Atherothrombosis”

Invited Lecture, Fourth World Congress of Cellular and Molecular Biology, Poitiers, France. “Cerebral vascular Effects of Hyperhomocysteinemia in Murine Models”

Workshop Chair, 5th International Conference on Homocysteine Metabolism, Milan, Italy. “Mechanisms of Homocysteine Toxicity, Animal Models, and the Homocystinurias”

Ob/Gyn Postgraduate Conference, Iowa City, IA. “Thrombophilia: Implications for Hormones and Pregnancy”

2004

Invited Lecture, Second International Symposium on ADMA: An Emerging Cardiovascular Risk Factor, New Orleans, LA. “ADMA and Hyperhomocysteinemia”

Invited Lecture, Canadian Cardiovascular Congress, Calgary, Alberta. “Vascular Effects of Hyperhomocysteinemia: Insights from Murine Models”

Keynote Lecture, Third Annual Meeting of the HOST Study, Santa Fe, NM. “Molecular and Cellular Mechanisms of Vascular Injury by Homocysteine”

Family Physician Refresher Course, University of Iowa. “Work-up for the Hypercoagulable State: When and How”

Internal Medicine Grand Rounds, University of Iowa. “Progress and Controversy in Anticoagulation”

2003

Iowa Anticoagulation Symposium. “Anticoagulation Management of Thrombophilias”

Visiting Professor, Henderson Research Centre, McMaster University, Hamilton, Ontario. “Mechanisms of Vascular Dysfunction in Hyperhomocysteinemia”

Plenary Lecture, Fourth International Conference on Homocysteine Metabolism, Basel, Switzerland. “Endothelial Dysfunction & Homocysteine: Studies in Mice Models with Moderate Hyperhomocysteinemia”

Visiting Professor, New York Medical College, Valhalla, NY. “Homocysteine and Vascular Function”

University of Arizona Cancer Center. “Platelet Procoagulant Activity in Mice”

2002

Visiting Professor, Sarver Heart Center, University of Arizona. “Vascular Dysfunction in Hyperhomocysteinemia and Atherosclerosis”

Plenary Lecture, First International Symposium on ADMA as a Cardiovascular Risk Factor, Hamburg, Germany. “Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA”

Invited Lecture, FASEB Summer Research Conference on Folic Acid, Vitamin B12, and One-Carbon Metabolism, Snowmass, CO. “Mechanisms of Endothelial Dysfunction”

Invited Lecture, Workshop on Pregnancy and Thrombosis, Berlin, Germany: “Evaluation and Management of Thrombophilia”

Invited Lecture, Institute for Experimental and Clinical Pharmacology and Toxicology, University of Hamburg-Eppendorf, Hamburg, Germany, “Homocysteine and Vascular Function”

2001

Invited Lecture, Division of Hematology, Washington University, St. Louis, MO, “Hyperhomocysteinemia”

Co-chair, “Activated Protein C Formation and Functions” International Society on Thrombosis and Haemostasis, Paris, France

Invited Lecture, FASEB Summer Research Conference on Thrombin and Vascular Medicine, Whitefish, MT. “Thrombin-dependent Anticoagulant Responses in Atherosclerosis”

Invited Lecture, Rockefeller University Clinical Scholars Program, New York, NY, “Hyperhomocysteinemia: Mediator or Marker of Vascular Disease?”

2000

Invited Lecture, The American Society of Nephrology Annual Meeting, Toronto, Ontario. “Homocysteine: Metabolism and Cell Pathobiology”

Invited Lecture, FASEB Summer Research Conference on Folic Acid, Vitamin B12, and One-Carbon Metabolism, Snowmass, CO. “Vascular Dysfunction in Hyperhomocysteinemic Mice”

Invited Lecture, International Symposium on Molecular Mechanism of Thrombosis and Its Regulation, Osaka, Japan. “Homocysteine and Atherosclerosis”

1999

Plenary Lecture, International Congress on Nutrition, Thrombosis, and Cardiovascular Diseases.  Rome, Italy  “Experimental Hyperhomocysteinemia in Laboratory Animals”

Chair, “Hematology & Oncology Session,” Annual Meeting of the Central Society of Clinical Research, Chicago, IL

1998

Co-chair, “Regulation of Coagulation Factor Function,” Annual Meeting of the American Society of Hematology, Miami, FL

Invited Lecture, Hamilton Civic Hospitals Research Centre, Hamilton, Ontario, Canada, “Endothelial Antithrombotic Function in Hyperhomocysteinemia”

Plenary Lecture, Agora Thrombosis Conference, Shiga Prefecture, Japan, "Mechanisms of Thrombosis in Hyperhomocysteinemia"

Invited Lecture, National Cardiovascular Research Institute, Osaka, Japan  “Endothelial Antithrombotic Function in Atherosclerosis”

Plenary Lecture, 2nd International Conference on Homocysteine Metabolism, Nijmegen, The Netherlands, “Pathogenesis of Hyperhomocysteinemia”

Glaxo Wellcome Research Seminar, Stevenage, UK. "Vascular Dysfunction in Hyperhomocysteinemia"

Invited Lecture, Department of Cell Biology, The Cleveland Clinic Foundation, Cleveland, OH, “Vascular Function in Hyperhomocyst(e)inemia and Atherosclerosis”

1997

Invited Lecture, Division of Hematology, Washington University, St. Louis, MO, “Antithrombotic Function in Hyperhomocyst(e)inemia and Atherosclerosis"

Visiting Professor, Markey Pathway Program, Washington University, St. Louis, MO, “Homocysteine and Thrombophilia”